Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Feltner D et al. – Placebo response is thought to be a primary contributor to uninformative (failed) trials in clinical drug development. Excluding the 56 patients from the analysis resulted in a greater separation of active treatment from placebo. The PRSS is a promising tool for predicting placebo response in clinical trials and requires further use and validation.

   

Related Articles

Social anxiety disorder in older adults: Evidence from the National Epidemiologic Survey on alcohol and related conditions
Journal of Affective Disorders, 11/11/09    Relevance Score: 70%

The Occurence of Mood and Anxiety Disorders in Heart Transplant Recipients
Transplantation Proceedings, 11/02/09    Relevance Score: 70%

Epidemiology and Management of Anxiety in Patients with Bipolar Disorder
CNS Drugs, 10/30/09    Relevance Score: 69%

Stability of childhood anxiety disorder diagnoses: a follow-up naturalistic study in psychiatric care
European Child and Adolescent Psychiatry, 10/28/09    Relevance Score: 69%

Identifying target groups for the prevention of anxiety disorders in the general population
Acta Psychiatrica Scandinavica, 10/15/09    Relevance Score: 69%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address